Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ZM-H1505R with Entecavir in Chronic Hepatitis B
NCT05484466Phase 2Unknown
- Sponsor
- Zhimeng Biopharma
- Start
- Nov 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of Canocapavir in Chronic Hepatitis B (CHB), sponsored by Zhimeng Biopharma. Status: unknown.
02
Drugs
Canocapavir
03
Conditions
Chronic Hepatitis B (CHB)
Beyond the preview
Go deeper on NCT05484466.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05484466.